Ethyl Acetate

Ethyl Acetate

SCHEMBL5083740

CCOC(C)=O.[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112159328-A Resolution method of dapoxetine 石家庄市度智医药科技有限公司 2021-01-01 CN claimed
CN-106032359-B Indazole compounds and its preparation method and application 复旦大学 2018-07-20 CN claimed
CN-106890542-A A kind of reaction end gas processing method 绍兴文理学院 2017-06-27 CN claimed
CN-106032359-A Indazole compounds, preparation method and applications thereof 复旦大学 2016-10-19 CN claimed
EP-4265606-A1 SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK PROTEIN KINASE INHIBITOR AND PREPARATION METHOD THEREFOR Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) 2023-10-25 EP disclosed
US-20230331696-A1 SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK INHIBITOR AND PREPARATION METHOD THEREFOR OCUSUN OPHTHALMIC PHARMACEUTICAL (GUANGZHOU) CO., LTD. (CN) 2023-10-19 US disclosed
WO-2023190472-A1 CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME 公益財団法人相模中央化学研究所 2023-10-05 WO disclosed
WO-2023083291-A1 DERIVATIVE OF ASPARTIC ACID AND USE THEREOF IN TREATMENT OF METABOLIC DISEASES SUCH AS HEPATIC FIBROSIS AND NON-ALCOHOLIC HEPATITIS 深圳利沃生物医药科技有限公司 2023-05-19 WO disclosed
WO-2023071218-A1 PYRAZOLOPYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 沈阳药科大学 2023-05-04 WO disclosed
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed
CN-114423766-A Penicilliane derivatives for the treatment of bacterial infections 丹诺医药(苏州)有限公司 2022-04-29 CN disclosed
WO-2021102774-A1 AMINE DERIVATIVE SERVING AS SSAO/VAP-1 INHIBITOR AND USE THEREOF 广东东阳光药业有限公司 2021-06-03 WO disclosed
CN-103242221-A Preparation method of dihydropyridine compound SHANGHAI INST PHARM INDUSTRY 2013-08-14 CN disclosed
CN-102850236-A Novel benzamide histone deacetylase inhibitor and application thereof SINOPHARM YIXIN PHARMACEUTICAL CO LTD 2013-01-02 CN disclosed
CN-101589333-B Liquid crystal aligning agent, liquid crystal alignment film using the same, and liquid crystal display element NISSAN CHEMICAL IND LTD 2011-06-08 CN disclosed
CN-101589333-A Liquid crystal orientating agent, the liquid crystal orientating membrane that has used this directing agent and liquid crystal display cells NISSAN CHEMICAL IND LTD (JP) 2009-11-25 CN disclosed
CN-101448800-A Novel compounds as cannabinoid receptor ligands and uses thereof ABBOTT LAB (US) 2009-06-03 CN disclosed
EP-1884508-A1 Process for the preparation of polyhydroxylated stilbenes via claisen condensation Portela &amp; Ca., S.A. (PT) 2008-02-06 EP disclosed
WO-2008012108-A2 PROCESS FOR THE PREPARATION OF POLYHYDROXYLATED STILBENES VIA CLAISEN CONDENSATION PORTELA & CA., S.A. (PT) 2008-01-31 WO disclosed
CN-85101149-A The preparation method of N-acyl group-hydroxyl and N-acyl group-acyloxy aromatic amine 1987-01-17 CN disclosed